FDA prüft Medikament von Merck & Co beschleunigt

07:59 EDT 2 Oct 2019 | FinanzNachrichten

Von Colin Kellaher NEW YORK (Dow Jones)--Die US-Gesundheitsbehörde FDA hat dem Pharmakonzern Merck & Co für zwei Anwendungen des Antibiotikums Dificid zur Behandlung einer Form der Diarrhoe bei Ki...

Original Article: FDA prüft Medikament von Merck & Co beschleunigt


More From BioPortfolio on "FDA prüft Medikament von Merck & Co beschleunigt"

Quick Search

Relevant Topics

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...